Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 60.55
+2.90 (5.03%)
At close: Mar 27, 2026
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 17.84 billion as of March 27, 2026. Its market cap has increased by 76.84% in one year.
Market Cap
17.84B
Enterprise Value
16.58B
Revenue
797.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
60.55
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 17.84B, a decrease of -3.20%. That is a compound annual growth rate of -0.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 16.98B | 7.86% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | 18.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 27.89B |
| InnoCare Pharma | 26.41B |
| Duality Biotherapeutics | 25.62B |
| Genscript Biotech | 24.27B |
| PegBio | 22.35B |
| Ascletis Pharma | 17.26B |
| Ascentage Pharma Group International | 15.74B |
| Zai Lab | 15.36B |